5 August 2025 

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Company")

Result of General Meeting

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that at the General Meeting ("GM") of the Company held at 10.00am today, both resolutions proposed at the meeting were duly passed by shareholders.

The full proxy results of the AGM will shortly be provided in the Investor Relations section of the Company's

website at   www.venture-life.com

For further information, please contact:

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, the Health and Her product range supporting the hormonal lifecycle, the UltraDEX and Dentyl oral care product ranges. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples and are sold in over 90 countries worldwide. In the UK, Ireland and the US these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

LEI: 213800S8CZUPLAB2KC70